Login

Paul Wright, CEO, Universal Biosensors Inc 00:00:00

Share On Facebook Share On Twitter

CEO Paul Wright discusses the company’s Q3 2015 results and product pipeline.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
WeWork's Resurgence: New IPO Performance and Market Adaptation
00:00:00
Lisa Anson, CEO, Redx Pharma
00:10:00
Valérie Baudson's Strategic Outlook for Amundi | Valérie Baudson, CEO, Amundi .
00:10:00
Dalet CEO Carl Farrell Discusses Cloud-Native Evolution and AI Integration in Media Production | Carl Farrell, CEO, Dalet SADLT:PAR
00:00:00
Glynn Wilson, CEO, TapImmune Inc
00:10:00
Understanding the Four Pillars of Capital: Insights from Caspar Helmore | Caspar Helmore, Partner - Client Management
00:10:00
Avaya CEO Jim Chirico's Interview with CNN's First Move | Donald Bugos , CEO, Communications Systems Inc VC9:BER
00:10:00
Discussion on Energy Sector Dynamics and Market Opportunities Revealed Through Dialogue Between Industry Experts | João Marques da Cruz, CEO, EDP Energias do Brasil SA .
00:10:00
Embark on a captivating exploration of Scott Durkin's illustrious career journey| Scott Durkin , CEO ,Douglas Elliman Inc.
00:10:00
Excelsior Mining's Stephen Twyerould Highlights Gunnison Copper Project's In-Situ Recovery and Environmental Benefits
00:10:00
Insights from SBI Chairman on India's Banking System and Economic Outlook | Dinesh Kumar Khara, Chairman , State Bank of India.
00:10:00
Immigrant Entrepreneur Life Science Business Awardee|Avak Kahvejian,General Partner,Flagship Pioneering

© 2026 Nehu